Literature DB >> 6605801

Functional consequence of variation in melanoma antigen expression.

L M Zehngebot, M A Alexander, D Guerry, D B Cines, K Mitchell, M Herlyn.   

Abstract

Melanoma cells have been shown to express melanoma-associated antigens and, in many cases, the histocompatibility antigen, HLA-DR. We questioned whether the expression of these antigens was quantitatively altered during the serial passage of melanoma cells in culture. Therefore, we measured the binding of monoclonal antibodies specific for a melanoma-specific antigen and the HLA-DR antigen to melanoma cells from serial passages. Three cell lines were studied. We found that although both the melanoma-associated antigen and the HLA-DR antigen were qualitatively conserved, significant quantitative differences were seen. To study the functional consequences of these differences, we used fluorescence-activated cell sorting to create DR-enriched and DR-depleted populations from a single melanoma cell line heterogeneous for DR expression. We found that the proliferation of allogeneic T cells (measured by the 3H-TdR uptake) cultured with the DR-enriched and -depleted melanoma cell populations was directly related to the amount of the HLA-DR antigen expressed. These results indicate that in performance of experiments using melanoma cell lines quantitative assessment of antigenic expression is important, particularly if the function of a specific antigen is under examination. Further, our data clearly identify the HLA-DR antigen on melanoma cells as a participant in allogeneic lymphocyte stimulation.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6605801     DOI: 10.1007/bf00199902

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  18 in total

1.  Expression of HL-A antigens in synchronized cultures of human lymphocytes.

Authors:  M A Pellegrino; S Ferrone; P G Natali; A Pellegrino; R A Reisfeld
Journal:  J Immunol       Date:  1972-02       Impact factor: 5.422

2.  A microtest radioimmunoassay for noncytotoxic tumor-specific antibody to cell-surface antigens.

Authors:  L T Goldstein; N R Klinman; L A Manson
Journal:  J Natl Cancer Inst       Date:  1973-11       Impact factor: 13.506

3.  Separation of leukocytes from blood and bone marrow. Introduction.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

4.  Cell cycle related heterogeneity of Ia antigen expression on a murine B lymphoma cell line:analysis by flow cytometry.

Authors:  L L Lanier; N L Warner
Journal:  J Immunol       Date:  1981-02       Impact factor: 5.422

5.  Structural characterization of the 'melanoma-specific' antigen detected by monoclonal antibody 691I5Nu-4-B.

Authors:  K F Mitchell; J P Fuhrer; Z Steplewski; H Koprowski
Journal:  Mol Immunol       Date:  1981-03       Impact factor: 4.407

6.  The detection of weak allogeneic stimulation by DR-positive tumor cell lines.

Authors:  M S Pollack
Journal:  Transplant Proc       Date:  1981-12       Impact factor: 1.066

7.  Heterogeneity of HLA-A,B, Ia-like, and melanoma-associated antigen expression by human melanoma cell lines analyzed with monoclonal antibodies and flow cytometry.

Authors:  S W Burchiel; J C Martin; K Imai; S Ferrone; N L Warner
Journal:  Cancer Res       Date:  1982-10       Impact factor: 12.701

8.  Analysis of the biosynthesis of HLA-DR glycoproteins in human malignant melanoma cell lines.

Authors:  K O Lloyd; J Ng; W G Dippold
Journal:  J Immunol       Date:  1981-06       Impact factor: 5.422

9.  Analysis of normal neoplastic human tissues for the tumor-associated protein p97.

Authors:  R G Woodbury; J P Brown; S M Loop; K E Hellström; I Hellström
Journal:  Int J Cancer       Date:  1981-02-15       Impact factor: 7.396

10.  Human melanoma associated antigens: a solid-phase assay for detection of specific antibody.

Authors:  A C Morgan; D R Galloway; B S Wilson; R A Reisfeld
Journal:  J Immunol Methods       Date:  1980       Impact factor: 2.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.